Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 7Unknown 4Terminated 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Warts 1Stomatitis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Condylomata Acuminata 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Zinc × Clear all
NCT04321850 2020-08-04

Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.

National Institute of Pediatrics, Mexico

Phase NA Terminated
21 enrolled
LymphoidOther hematologic neoplasm

Stomatitis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01468636 2016-11-02

A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts

University of British Columbia

Phase 4 Terminated
50 enrolled

Condylomata Acuminata, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡